<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01229384</url>
  </required_header>
  <id_info>
    <org_study_id>BronchPAP</org_study_id>
    <nct_id>NCT01229384</nct_id>
  </id_info>
  <brief_title>Randomized Controlled Trial Comparing Standard Versus Positive Pressure Nebulization in Infants With Bronchiolitis to Reduce Hospital Admissions</brief_title>
  <acronym>BPAP</acronym>
  <official_title>Randomized Controlled Trial Comparing Standard Versus Positive Pressure Nebulization in Infants With Bronchiolitis to Reduce Hospital Admissions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Phoenix Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Phoenix Children's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: That administration of nebulized therapy for bronchiolitis when using positive
      airway pressure is superior to standard mask ventilation in reducing hospital admissions.

      Bronchiolitis is a lower respiratory tract infection (LRTI) syndrome caused by a variety of
      different viruses. It is the most common LRTI in children under 24 months old. Multiple
      studies have documented variation in treatment, hospitalization rates, and length of hospital
      stay for bronchiolitis, suggesting a lack of consensus and an opportunity to improve care for
      this common disorder.

      Research to determine optimal delivery methods of respiratory medications that may augment
      oxygenation by decreasing atelectasis (Lung cell collapse) and increasing oxygen saturation
      have not been done. Currently bronchodilators are delivered through a passive process,
      inhaled as they are nebulized (made from liquid into gas) into a face mask. This study will
      evaluate whether using a newly developed positive pressure nebulization device that uses
      pressure to expand lung cells and, hypothetically, deliver the medication better, improves
      oxygenation by reducing atelectasis (lung cell collapse) to decrease hospitalization in
      infants with moderate to severe bronchiolitis.

      Positive pressure nebulization is a relatively new adaptation of a previously existing
      modality, and is already currently in use here at PCH.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospitalization Rates</measure>
    <time_frame>2 weeks</time_frame>
    <description>Will measure rate of hospitalization of children comparing those treated with positive airway pressure nebulization and those with standard nebulization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in bronchiolitis Score</measure>
    <time_frame>day of presentation</time_frame>
    <description>Will measure change in bronchiolitis score by repiratory therapy of children comparing those treated with positive airway pressure nebulization and those with standard nebulization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Oxygen Saturation</measure>
    <time_frame>Day of presentation</time_frame>
    <description>Will measure change in oxygen saturation of children comparing those treated with positive airway pressure nebulization and those with standard nebulization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intensive Care Unit Admission Rate</measure>
    <time_frame>day of presentation</time_frame>
    <description>Will measure rate of hospitalization in the intensive care unit of children comparing those treated with positive airway pressure nebulization and those with standard nebulization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay</measure>
    <time_frame>To be determined</time_frame>
    <description>Will measure length of hospitalization of children comparing those treated with positive airway pressure nebulization and those with standard nebulization.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unscheduled Return to the Emergency Department</measure>
    <time_frame>2 weeks</time_frame>
    <description>Will measure rate of unscheduled return to the ED of children comparing those treated with positive airway pressure nebulization and those with standard nebulization.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Bronchiolitis</condition>
  <arm_group>
    <arm_group_label>Positive Airway Pressure Nebulization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will administer nebulized medications using Positive Airway Pressure Nebulization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Nebulization</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Current standard of administering nebulized medications without positive airway pressure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Positive Airway Pressure nebulization</intervention_name>
    <description>Using a device approved in pediatrics to deliver nebulized treatments of albuterol and racemic epinephrine with positive pressure</description>
    <arm_group_label>Positive Airway Pressure Nebulization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard passive nebulization of respiratory medications</intervention_name>
    <description>Patients will receive standard passively inhaled nebulized albuterol and racemic epinephrine.</description>
    <arm_group_label>Standard Nebulization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants 2-24 months with moderate to severe bronchiolitis

        Exclusion Criteria:

          -  Those outside the age range of 2-24 months, or less than postconceptual age of 48weeks
             for premature infants

          -  Those with comorbid conditions such as cyanotic heart disease, home oxygen use,
             tracheostomy use, or other serious medical conditions.

          -  Those with history of apnea
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Months</minimum_age>
    <maximum_age>24 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zebulon J Timmons, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Phoenix Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Hostetler, MD</last_name>
    <role>Study Director</role>
    <affiliation>Phoenix Children's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zebulon J Timmons, MD</last_name>
    <phone>402-203-9303</phone>
    <email>ztimmons@phoenixchildrens.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mark Hostetler, MD</last_name>
    <phone>602-546-1910</phone>
    <email>mhostetler@phoenixchildrens.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Phoenix Children's Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lara Hale, BA</last_name>
      <phone>602-546-1910</phone>
      <email>lhale@phoenixchildrens.com</email>
    </contact>
    <contact_backup>
      <last_name>David Bank, MD</last_name>
      <phone>602-546-1910</phone>
      <email>dbank@phoenixchildrens.com</email>
    </contact_backup>
    <investigator>
      <last_name>Zebulon J Timmons, BA, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Hostetler, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Bank, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dawn Barcellona, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Blake Bulloch, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tom McConahay, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rustin Morse, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Theresa Murdock, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anthony Pickett, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tamara Pottker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chris Ramsook, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lalitha Ravi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karen Scharlatt, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kopal Seth, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Yniguez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephanie Zimmerman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ming Chien, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Angelique Ferayorni, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amanda Kasem, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>William Schneider, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karem Collindres-Duque, DO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amanda Queen, PA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lisa Keller, NP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jessica Snow, NP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carol Thrall, NP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Becky Brown, NP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Scharon Schaeffer, NP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Candy Schmitz, NP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2010</study_first_submitted>
  <study_first_submitted_qc>October 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2010</study_first_posted>
  <last_update_submitted>June 8, 2012</last_update_submitted>
  <last_update_submitted_qc>June 8, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 11, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Phoenix Children's Hospital</investigator_affiliation>
    <investigator_full_name>Mark Hostetler</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

